We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Generics company Vensun raises $22.5mm in Series C round
02 Dec 2016
Executive Summary
Vensun Pharmaceuticals Inc. (generic drugs) raised $22.5mm in its Series C financing round. The round was led by Perceptive Advisors, and included participation from new investor Deerfield Management, along with existing investors JW Asset Management, company management, and entities affiliated with Dr. Allen Chao, the co-founder of Watson Pharmaceuticals. Michael Altman of Perceptive was appointed to Vensun's Board.
Deal Industry
Pharmaceuticals
Pharmaceuticals
Generic Drugs
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?